0001415889-15-002567.txt : 20150806 0001415889-15-002567.hdr.sgml : 20150806 20150806060455 ACCESSION NUMBER: 0001415889-15-002567 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20150806 DATE AS OF CHANGE: 20150806 EFFECTIVENESS DATE: 20150806 FILER: COMPANY DATA: COMPANY CONFORMED NAME: INNOVUS PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001411879 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 870324697 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-245186 FILM NUMBER: 151030979 BUSINESS ADDRESS: STREET 1: 4275 EXECUTIVE SQUARE, SUITE 200 CITY: LA JOLLA STATE: CA ZIP: 92037 BUSINESS PHONE: 858-964-5123 MAIL ADDRESS: STREET 1: 4275 EXECUTIVE SQUARE, SUITE 200 CITY: LA JOLLA STATE: CA ZIP: 92037 FORMER COMPANY: FORMER CONFORMED NAME: North Horizon, Inc. DATE OF NAME CHANGE: 20070910 D 1 primary_doc.xml X0707 D LIVE 0001411879 INNOVUS PHARMACEUTICALS, INC. 9171 Towne Centre Drive, Suite 440 San Diego CA CALIFORNIA 92122 (858) 964-5123 NEVADA None North Horizon, Inc. Corporation true Bassam Damaj 9171 Towne Centre Drive, Suite 440 San Diego CA CALIFORNIA 92122 Executive Officer Director Vivian Liu 9171 Towne Centre Drive, Suite 440 San Diego CA CALIFORNIA 92122 Director Henry Esber 9171 Towne Centre Drive, Suite 440 San Diego CA CALIFORNIA 92122 Director Ziad Mirza 9171 Towne Centre Drive, Suite 440 San Diego CA CALIFORNIA 92122 Director Pharmaceuticals Decline to Disclose 06b false 2015-08-03 false true true true false 0 1500000 500000 1000000 1,250,00 issuance of restricted stock, issuance of warrant for up to 500,000 shares of common stock at $0.30 exercise price and convertible promissory note of $550,000 at $0.30 conversion price. false 0 0 0 0 0 INNOVUS PHARMACEUTICALS, INC. /s/ Bassam Damaj Bassam Damaj President and CEO 2015-08-06